Bouchemaine, France

Pascale Jeannin

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.3

ph-index = 1


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Pascale Jeannin: Innovator in Medical Treatments

Introduction

Pascale Jeannin is a notable inventor based in Bouchemaine, France. He has made significant contributions to the field of medical treatments, particularly in the area of thrombotic microangiopathies. With a total of 3 patents to his name, Jeannin's work is recognized for its innovative approaches to complex medical conditions.

Latest Patents

One of Jeannin's latest patents focuses on the use of clusterin for the treatment of thrombotic microangiopathies. This invention includes a pharmaceutical composition comprising clusterin, which does not contain von Willebrand factor protease. Additionally, the patent outlines an ex vivo method for stratifying patients likely to suffer from thrombotic microangiopathies. This method involves measuring the amount of clusterin in a biological sample and comparing it to a predetermined threshold to determine the patient's likelihood of benefiting from treatment.

Another significant patent involves the development of bioresorbable nonlamellar microparticles. These microparticles are designed to bond with protein substances and are prepared without stabilizers or surfactants. This innovative method enhances the potential applications of these microparticles in various medical treatments.

Career Highlights

Pascale Jeannin has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Bordeaux. His experience in these organizations has contributed to his expertise and success as an inventor in the medical field.

Collaborations

Throughout his career, Jeannin has collaborated with notable colleagues, including Yasemin Ataman-Onal and Thierry Delair. These partnerships have likely enriched his research and development efforts, leading to impactful innovations.

Conclusion

Pascale Jeannin's contributions to medical innovation, particularly in the treatment of thrombotic microangiopathies, highlight his role as a significant inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…